Crisis & Reputation Risk Management

MeridianPharma • Event: Contamination Allegation (Unsubstantiated) • T+6H Active

CRISIS ACTIVE
Crisis Escalation Score
71
▲ 43 from baseline
Negative Story Velocity
11/hr
▼ 3 from peak
Sentiment Momentum
-0.22
▼ 0.63 from baseline
Message Penetration
28%
Target: 30%+ @ T+4H
Social Amplif. Ratio
8.3x
▲ 6.1x from baseline
BEaR (Value at Risk)
$14.2M
3.0% of ARR
Crisis Timeline – Last 6 Hours
Sentiment Momentum Index
Journalist Amplification Tier
Spokesperson Message Penetration
Social Amplification Ratio
Journalist & Outlet Coverage Heatmap (Last 6 Hours)
T-6H
T-5H
T-4H
T-3H
T-2H
T-1H
WSJ (Tier 1)
2
5
4
3
2
1
Reuters (T1)
1
3
4
3
2
1
Bloomberg (T1)
0
2
2
1
1
0
FiercePharma (T2)
1
2
1
2
1
0
Endpoints (T2)
0
1
1
1
0
0
Local News (T3)
2
4
5
6
4
3
Intensity: 0 (white) → 1-2 (beige) → 3+ (coral)
Fringe Forum Mentions
47
▲ 39 mentions (last 6H)
Reddit: 28 • 4chan: 12 • Telegram: 7
Sentiment Recovery Half-Life
18.4h
Target: <24h
Projected SMI baseline return: T+18H
Corrective Coverage Ratio
0.19
Target: >0.40 by T+12H
9 corrective / 47 negative articles
Crisis Article Detail (Last 6 Hours)
Time Outlet Headline Tier Sentiment Social Shares SMPR
T-5H 42m WSJ MeridianPharma faces contamination claims on social media Tier 1 -0.78 2,847 12%
T-4H 18m Reuters Pharma company responds to contamination allegation Tier 1 -0.32 1,523 41%
T-3H 51m Bloomberg Social media post sparks MeridianPharma stock volatility Tier 1 -0.61 1,982 8%
T-3H 22m FiercePharma MeridianPharma CEO issues statement on contamination Tier 2 -0.19 742 67%
T-2H 44m Endpoints News Initial testing shows no contamination in MeridianPharma batch Tier 2 +0.22 418 53%
T-2H 09m Local ABC Patients express concern over MeridianPharma product safety Tier 3 -0.84 1,247 3%
T-1H 33m WSJ FDA has not received formal complaint about MeridianPharma Tier 1 +0.14 894 38%
T-47m Reuters Third-party lab confirms no contamination in Meridian batch Tier 1 +0.41 623 72%